A drug is called “orphan” when it is intended for treating rare diseases. This situation deters the pharmaceutical industries from investing in this kind of products.
You are here
"UK Taxation and Business Opportunities": Workshop Organised Jointly by Interconsulting, Pragma and DFK
Seminar "Succession Planning Contemplated in Switzerland for Residents in Italy, 2.0 Voluntary Disclosure and Fiscal Monitoring"